Novel Remyelination AssayOligodendrocytes wrap around glass micropillars, allowing high-throughput assays of potential remyelination agents.
Axon Transport Deficits
Myelin and Axons Don’t Form a Uniform Union
Innate Differences in Demyelination
Welcome to the Multiple Sclerosis Discovery Forum
Episode 55 of the MSDF podcast features Michael Levy, MD, PhD, of Johns Hopkins University School of Medicine, who discusses the status of regenerative stem cell therapies for multiple sclerosis.
Tools that will help investigators conceive and perform experimental work:
The Data Visualization section presents MS-related data in new ways, making it easy for viewers to discover unexpected relationships
Our latest data visualization presents a set of word clouds that allow you see the most common terms used in scientific studies describing multiple sclerosis clinical trials.
- Drug-Development Pipeline consolidates key information about compounds under investigation for therapeutic use
We've recently added 13 new trials, updated information on 28 trials, and added 74 other pieces of information. The drugs with important additions and changes are alemtuzumab, BAF312, BIIB033, daclizumab, dalfampridine, dimethyl fumarate, fingolimod, glatiramer acetate, interferon β-1a, interferon β-1b, laquinimod, mitoxantrone, naltrexone, natalizumab, phenytoin, rituximab, RPC1063, and teriflunomide.
- Tissue Repositories lists features of the world's tissue repositories and brain banks, including rules of engagement and contact information
- MSGene provides a comprehensive, unbiased and regularly updated collection of genetic association studies performed on multiple sclerosis phenotypes
- Clinical Trials lists sources of information about MS clinical trials
Meetings and Events catalogs future and past meetings of interest to the MS-research community
- Funding Opportunities provides information about where to obtain grants
- Jobs offers descriptions of available positions
Member Directory displays profiles of MS-research community members
Bulletin Board allows MSDF members to post notices
Useful Links lists helpful resources elsewhere on the web
Amyloid has potent anti-inflammatory abilities which may explain what it is trying to do in Alzhe
Does anyone know anything more about this?
When will this study be completed?